Uncover key drivers, emerging technologies, and competitive movements shaping the hospital acquired infections testing kits market from 2025–2034 with trusted insights from The Business Research Company
What Are The Market Size Estimates For The Hospital Acquired Infections Testing Kits Market Now And By 2029?
The hospital acquired infections testing kits market size has shown strong growth in recent years. It is anticipated to increase from $4.54 billion in 2024 to $4.79 billion in 2025, at a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to a surge in hospital-acquired infections (HAIs), an expanding aging population, and a higher volume of surgical procedures.
The market for hospital acquired infections testing kits is projected to experience substantial expansion in the coming years. This market is anticipated to reach $6.64 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.5%. This expansion during the projection period stems from factors such as a rise in chronic diseases, increased healthcare spending, and augmented government backing. Key developments anticipated in the forecast timeframe involve collaborations with artificial intelligence firms, utilizing government assistance, integrating big data into market assessments, and forging partnerships with other industry participants.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp
Which Long-Term Drivers Are Expected To Sustain The Hospital Acquired Infections Testing Kits Market?
Hospital-acquired infections (HAIs) are experiencing a rise, impacting both individuals admitted to hospitals and those visiting for outpatient care. These infections, also termed nosocomial infections, are illnesses contracted within hospital environments and medical clinics. For example, according to data from the Center for Disease Control and Prevention, about **1.7 million** people in the **USA** contract hospital-acquired infections while being hospitalized for other health concerns, and more than **98,000** (approximately **5%**) patients die as a result of these infections. The escalating occurrence of hospital-acquired infections subsequently boosts the demand for the **hospital-acquired infections testing kits market**.
How Is The Hospital Acquired Infections Testing Kits Market Classified By Different Segments?
The hospital acquired infections testing kitsmarket covered in this report is segmented –
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing
Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)
What Current And Upcoming Trends Are Shaping The Hospital Acquired Infections Testing Kits Market?
Technologies utilized in diagnosing healthcare-associated infections (HAIs), encompassing flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based methods, are experiencing technological advancements, leading to the provision of more precise data. A notable progression has occurred in mass spectrometers, which are now able to quantify identified materials and pinpoint unknown compounds within a sample. For instance, SCIEX’s X500 QTOF addresses contamination challenges and serves as a compact device that maintains high resolution and accuracy. It expedites result generation, empowering operators to make data-driven decisions more swiftly.
Who Are The Primary Market Leaders In The Hospital Acquired Infections Testing Kits Market?
Major companies operating in the hospital acquired infections testing kits market include Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, Siemens Healthineers
Download The Full Report Here:
Which Regional Markets Are Emerging As Key Centers For The Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp
Browse Through More Reports Similar to the Global Hospital Acquired Infections Testing Kits Market 2025, By The Business Research Company
Hospital Acquired Infection Control Global Market Report 2025
Healthcare Personal Protective Equipment Global Market Report 2025
Hospital Supplies Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hospital-supplies-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
